Craneware plc (CRWRF)
OTCMKTS
· Delayed Price · Currency is USD
27.32
+3.04 (12.51%)
At close: May 16, 2025
Craneware Revenue
Craneware had revenue of $100.05M in the half year ending December 31, 2024, with 18.16% growth. This brings the company's revenue in the last twelve months to $198.10M, up 9.71% year-over-year. In the fiscal year ending June 30, 2024, Craneware had annual revenue of $189.27M with 8.76% growth.
Revenue (ttm)
198.10M
Revenue Growth
+9.71%
P/S Ratio
5.06
Revenue / Employee
265.19K
Employees
747
Market Cap
1.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 189.27M | 15.25M | 8.76% |
| Jun 30, 2023 | 174.02M | 8.47M | 5.12% |
| Jun 30, 2022 | 165.54M | 89.97M | 119.04% |
| Jun 30, 2021 | 75.58M | 4.09M | 5.72% |
| Jun 30, 2020 | 71.49M | 91.00K | 0.13% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
| BioStem Technologies | 332.45M |
Craneware News
- 6 days ago - Private equity giant Bain mulls bid for London-listed software firm Craneware - Evening Standard
- 2 months ago - Craneware PLC (CRWRF) (H1 2025) Earnings Call Highlights: Record Revenue and Strategic ... - GuruFocus
- 2 months ago - Half Year 2025 Craneware PLC Earnings Call Transcript - GuruFocus